Zephyr Valve Led to Sustained Benefits in Homogeneous Emphysema

Zephyr Valve Led to Sustained Benefits in Homogeneous Emphysema

301081

Zephyr Valve Led to Sustained Benefits in Homogeneous Emphysema

The Zephyr Endobronchial Valve leads to sustained and significant improvements in lung function, exercise capacity, and quality of life in people with homogeneous emphysema, a severe form of chronic obstructive pulmonary disease (COPD), according to one-year data from the IMPACT clinical study. “This is very important data because patients with severe COPD/emphysema have few treatment options once medications no longer alleviate symptoms,” Ralf Eberhardt, MD, one of the study’s co-principal investigators and a professor of…

You must be logged in to read/download the full post.